Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPARα)

Carcinogenesis

Volumn 19, Issue 1, 1998, Pages 43-48

  Roberts, Ruth A ^a   James, Neil H ^a   Woodyatt, Nicola J ^a   Macdonald, Neil ^a   Tugwood, Jonathan D ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NAFENOPIN; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHENOBARBITAL; RETINOID X RECEPTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIMERIZATION; DNA TRANSFECTION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CULTURE; MOLECULAR CLONING; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; REPORTER GENE; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; DNA PRIMERS; GENES, REPORTER; HUMANS; LIVER; LIVER NEOPLASMS; LYMPHOTOXIN-ALPHA; MALE; MICE; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031819433     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.1.43     Document Type: Article

References (35)

1. Moody, D.E., Reddy, J.K., Lake, B.G., Popp, J.A. and Reese, D.H. (1991) Peroxisome proliferation and non-genotoxic carcinogenesis: commentary on a symposium. Fund. Appl. Toxicol., 6, 233-248.
2. Reddy, J.K. and Lalwani, N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators. Evaluation of the risk of hypolidaemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol., 12, 1-58.
3. Ashby, J., Brady, A., Elcombe, C.R., Elliot, B.M., Ishmael, J., Odum, J., Tugwood, J.D., Kettle, S. and Purchase, I.F.H. (1994) Mechanistically-based human hazard assessment of peroxisome-proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol., 13, S1-S117.
4. Elcombe, C.R. and Mitchell, A. (1986) Peroxisome proliferation due to di(2-ethyl) phthalate: species differences and possible mechanisms. Environ. Hlth Perspect., 70, 211-219.
5. Bentley, P., Calder, I., Elcombe, E., Grasso, P., Stringer, D. and Wiegand, H.J. (1993) Hepatic peroxisome proliferation in rodents and its significance to humans. Fd. Chem. Toxic., 31, 857-907.
6. Ames, B.N. and Gold, L.S. (1990) Too many rodent carcinogens: mitogenesis increases mutagenesis. Science, 249, 970-971.
7. Schulte-Hermann, R. (1979) Adaptive liver growth induced by xenobiotic compounds: its nature and mechanism. Arch. Toxicol. Suppl., 2, 113-124.
8. Fausto, N. and Webber, E.M. (1993) Control of liver growth. Crit. Rev. Eukaryot. Gene Expr., 3, 117-135.
9. Alison, M.R. and Sarraf, C.E. (1995) Apoptosis: regulation and relevance to toxicology. Hum. Exp. Toxicol., 14, 234-247.
10. Bayly, A.C., Roberts, R.A. and Dive, C. (1994) Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator, nafenopin. J. Cell Biol., 125, 197-203.
11. James, N.H. and Roberts, R.A. (1996) Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than with suppression of apoptosis. Carcinogenesis, 17, 1623-1632.
12. Strange, J. and Roberts, R.A. (1996) Reduced expression of mature TGFβ1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin. Mutat. Res., 372, 107-113.
13. Roberts, R.A., Soames, A.R., Gill, J.H., James, N.H. and Wheeldon, E.B. (1995) Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different discrete hepatocyte populations. Carcinogenesis, 16, 1693-1698.
14. Issemann, I. and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645-650.
15. Mangelsdorf, D.J., Thummel, C., Beato, M. et al. (1995) The nuclear receptor superfamily: the second decade. Cell, 83, 835-839.
16. Lee, S.S.-T., Pineau, T., Drago, J., Lee, E.J., Owens, J.O., Kroetz, D.L., Fernandez-Salguero, P.M., Westphal, H. and Gonzalez, F.J. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleitrophic effects of peroxisome proliferators. Mol. Cell. Biol., 15, 3012-3022.
17. Kliewer, S.A., Umesono, K., Noonan, D.J., Heyman, R.A. and Evans, R.M. (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature, 358, 771-774.
18. Issemann, I., Prince, R.A., Tugwood, J.D. and Green, S. (1993) The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrin., 11, 37-47.
19. Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R., McPheat, W.L. and Green, S. (1992) The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J., 11, 433-439.
20. Gulick, T., Cresci, S., Caira, T., Moore, D.D. and Kelly, D.P. (1994) The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl Acad. Sci. USA, 91, 11012-11016.
21. Aldridge, T.C., Tugwood, J.D. and Green, S. (1995) Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J., 306, 473-479.
22. Muerhoff, A.S., Griffin, K.J. and Johnson, E.F. (1992) The peroxisome proliferator activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid w-hydroxylase by clofibric acid. J. Biol. Chem., 267, 19051-19053.
23. Kozak, M. (1984) Compilation and analysis of sequencesupstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res., 2, 857-872.
24. Seglen, P.O. (1973) Preparation of rat liver cells. III. Enzymatic requirements for tissue dispersion. Exp. Cell Res., 82, 391-398.
25. Cary, N.C. (1989) SAS/STAT User's Guide. SAS Institute Incorporated, New York.
26. Yen, P.M. and Chin, W.W. (1994) Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol. Endocrinol., 8, 1450-1454.
27. Liang, Q., He, J.S. and Fulco, J.S. (1995)The role of Barbie box sequences as cis-acting elements involved in the barbiturate-mediated induction of cytochromes P450BM-1 and P450BM-3 in Bacillus megaterium. J. Biol. Chem., 270, 4438-4450.
28. Rolfe, M., James, N.H. and Roberts, R.A. (1997) Tumour necrosis factor α (TNF-α) suppreses apoptosis and induces S-phase in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis, 18, 2277-2280.
29. Decker, K. (1990) Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem., 192, 245-261.
30. Bojes, H.K. and Thurman, R.G. (1996) Peroxisome proliferators activate kupffer cells in vivo. Cancer Res., 56, 1-4.
31. Bojes, H.K., Germolec, D.R., Simeonova, P., Bruccolrei, A., Schoonhoven, R., Luster, M.I. and Thurman, R.G. (1997) Antibodies to tumor necrosis factor-alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator WY-14,643. Carcinogenesis, 18, 669-674.
32. Hendriks, H.F.J., Brouwer, A. and Knook, D.L. (1991) Isolation, purification and characterisation of liver cell types. Methods Enzymol., 190, 49-58.
33. Williams, G.M. and Perrone, C. (1995) Mechanism-based risk assessment of peroxisome proliferating rodent hepatocarcinogens. In Reddy, J.K., Suga, T., Mannaerts, G.P., Lazarow, P.B. and Subramani, S. (eds) Peroxisomes: Biology and Role in Toxicology and Disease. The New York Academy of Sciences, New York, pp. 554-572.
34. Sher, T., Yi, H.F., McBride, W. and Gonzalez, F.J. (1993) cDNA cloning, chromosomal mapping and functional characterisation of the human peroxisome proliferator-activated receptor. Biochemistry, 32, 5598-5604.
35. Mukherjee, R., Jow, L., Noonan, D. and McDonnell, D.P. (1994) Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J. Steroid Biochem., 51, 157-166.